Dr. Jeremy Pantin, MD
Claim this profileSarah Cannon at TriStar Bone Marrow Transplant Center
Studies Acute Myelogenous Leukemia
Studies Leukemia
11 reported clinical trials
29 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
HLA positive
HLA negative
RB1 positive
2Leukemia
HLA positive
HLA negative
RB1 positive
Affiliated Hospitals
Clinical Trials Jeremy Pantin, MD is currently running
Bone Marrow Transplant
for Leukemia
This trial is testing the safety of using bone marrow from a deceased donor to treat patients with severe leukemia. The goal is to see if this new bone marrow can help produce healthy blood cells. Patients will be monitored closely for any side effects and overall effectiveness over several months.
Recruiting1 award Phase 1 & 210 criteria
Reduced-Dose Cyclophosphamide
for Leukemia After Stem Cell Transplant
The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving an HLA-Mismatched Unrelated Donor (MMUD) . The main question\[s\] it aims to answer are: * Does a reduced dose of PTCy reduce the occurrence of infections in the first 100 days after transplant? * Does a reduced dose of PTCy maintain the same level of protection against Graft Versus Host Disease (GvHD) as the standard dose of PTCy?
Recruiting1 award Phase 2
More about Jeremy Pantin, MD
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jeremy Pantin, MD has experience with
- Fludarabine
- Cyclophosphamide
- Tacrolimus
- Mycophenolate Mofetil
- Placebo
- Busulfan
Breakdown of trials Jeremy Pantin, MD has run
Acute Myelogenous Leukemia
Leukemia
Myelodysplastic Syndrome
Acute Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy Pantin, MD specialize in?
Jeremy Pantin, MD focuses on Acute Myelogenous Leukemia and Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA positive patients, or patients who are HLA negative.
Is Jeremy Pantin, MD currently recruiting for clinical trials?
Yes, Jeremy Pantin, MD is currently recruiting for 3 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Jeremy Pantin, MD has studied deeply?
Yes, Jeremy Pantin, MD has studied treatments such as Fludarabine, Cyclophosphamide, Tacrolimus.
What is the best way to schedule an appointment with Jeremy Pantin, MD?
Apply for one of the trials that Jeremy Pantin, MD is conducting.
What is the office address of Jeremy Pantin, MD?
The office of Jeremy Pantin, MD is located at: Sarah Cannon at TriStar Bone Marrow Transplant Center, Nashville, Tennessee 37203 United States. This is the address for their practice at the Sarah Cannon at TriStar Bone Marrow Transplant Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.